top of page



"The best way to predict the future is to invent it."
Alan Kay

F1901: LEAD CANDIDATE FOR INTRATUMORAL IMMUNE-THERAPY IN VETERINARY MEDICINE
​​
“F1901 is indicated in canine oral solid tumors grade I to III such as melanoma and squamous cell carcinoma”
-
F1901 is an innate immune system enhancer having great potential for targeting different types of cancer, and is set to become a blockbuster in immunotherapy.
-
F1901 mechanism of action has been extensively studied at Gustave Roussy.
-
In immunocompetent murine models, F1901 has been shown to:
-
Induce immunogenic tumor cell death and antitumor vaccination with a dose response effect
-
Enhance response to anti-PD1
-
-
Because of their similar biology and response to treatment, canine solid tumors may serve as a translational model for human cancer.

bottom of page